Slovenia
Tuberculosis profile
Population  2013 2.1 million
Estimates of TB burden * 2013 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.021 (0.021–0.021) 1 (1–1)
Mortality (HIV+TB only) 0 (–) 0 (–)
Prevalence  (includes HIV+TB) 0.19 (0.074–0.36) 9.2 (3.6–17)
Incidence  (includes HIV+TB) 0.16 (0.15–0.18) 7.5 (7.2–8.5)
Incidence (HIV+TB only) <0.01 (<0.01–<0.01) 0.06 (0.01–0.17)
Case detection, all forms (%) 89 (79–93)    
Estimates of MDR-TB burden * 2013   New   Retreatment
% of TB cases with MDR-TB 0 (0–3.6) 0 (0–46)
MDR-TB cases among notified pulmonary
TB cases
0 (0–4) 0 (0–3)
TB case notifications 2013 New ** Relapse
Pulmonary, bacteriologically confirmed 101   5
Pulmonary, clinically diagnosed 2   0
Extrapulmonary 30   1
       
Total new and relapse 139    
Previously treated, excluding relapses 1    
Total cases notified 140    
Among 139 new and relapse cases:
2 (1%) cases aged under 15 years; male:female ratio: 1.0
Reported cases of RR-/MDR-TB 2013 New Retreatment Total **
Cases tested for RR-/MDR-TB 100 (99%) 6 (86%) 106
Laboratory-confirmed RR-/MDR-TB cases     0
Patients started on MDR-TB treatment     0
TB/HIV 2013 Number (%)
TB patients with known HIV status 105 (75)
HIV-positive TB patients 1 (<1)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT) 1 (100)
HIV-positive TB patients on antiretroviral therapy (ART) 1 (100)
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate (%)
New and relapse cases registered in 2012 81
Previously treated cases, excluding relapse, registered in 2012  
HIV-positive TB cases, all types, registered in 2012  
RR-/MDR-TB cases started on second-line treatment in 2011  
XDR-TB cases started on second-line treatment in 2011  
Laboratories 2013  
Is second-line drug susceptibility testing available? Yes, in and outside
country
Financing TB control 2014  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2015-07-07 Data: www.who.int/tb/data